ANBP2

The Second Australian National Blood Pressure (ANBP2) Follow-up Study

CCRE Therapeutics is leading the ANBP2 Follow-up Study which examines the risk of heart failure in older Australians with hypertension (high blood pressure). Through data linkage with the National Death Index and re-contacting of participants 10-years after completion of the original study, this follow-up study will determine the long-term cardiovascular consequences of anti-hypertensive treatment.